Press release
Non-Alcoholic Steatohepatitis Market Size 2021: leading players, Regional Production Volume, Opportunities, Segments and Forecast Analysis 2028 - 180 Life Corp, 180 Life Sciences Corp, 89bio Inc, AbbVie Inc
The Non-Alcoholic Steatohepatitis Market Report 2021 report provides the latest industry data and future industry trends. The report lists leading competitors and manufacturers in the Non-Alcoholic Steatohepatitis industry and provides strategic industry insights and analysis of factors influencing the competitiveness of the market. The geographical scope of the Non-Alcoholic Steatohepatitis market is studied. The forecast market information, SWOT analysis, market scenario, and feasibility study are the vital aspects analyzed in this report.Our analysts predict that the market size is set to grow at robust CAGR of 47.2% during the 2021-2028 periods
Request Sample Copy of this Report:
https://www.marketintelligencedata.com/reports/3419297/non-alcoholic-steatohepatitis-nash-drugs-in-development-by-stages-target-moa-roa-molecule-type-and-key-players-2021-update/inquiry?mode=DivyA
Leading Players in the Non-Alcoholic Steatohepatitis Market- 180 Life Corp, 180 Life Sciences Corp, 89bio Inc, AbbVie Inc, ABIONYX Pharma SA, Abivax SA, Abliva AB, Ache Laboratorios Farmaceuticos SA, Acquist Theraputics Inc, AdAlta Ltd, Addpharma Inc, Afimmune Biopharma Ltd, Akebia Therapeutics Inc, Akero Therapeutics Inc, Albireo Pharma Inc, Aldeyra Therapeutics Inc, Algernon Pharmaceuticals Inc, Altavant Sciences Inc, Altay Therapeutics Inc, Alteogen Inc, Altimmune Inc, Amgen Inc, Amytrx Therapeutics Inc, Angion Biomedica Corp, Anteris Bio, Anyuan Pharmaceutical Technology (Shanghai) Co Ltd, AptaBio Therapeutics Inc, AptamiR Therapeutics Inc, Araim Pharmaceuticals Inc, Arcturus Therapeutics Holdings Inc, Aria Pharmaceuticals Inc, and other.
Industry News and Updates -
Aldeyra Therapeutics has acquired 1 company, including 1 in the last 5 years. Aldeyra Therapeutics has acquired in 1 US state. The Company's most targeted sectors include life science (100%).
AbbVie has acquired 6 companies, including 3 in the last 5 years. It has also divested 1 asset. AbbVie's largest acquisition to date was in 2019, when it acquired Allergan for $63.0B. It's largest disclosed sale occurred in 2020, when it sold Rare Pediatric Disease Priority Review Voucher to United Therapeutics for $105M. AbbVie has acquired in 4 different US states, and 2 countries. The Company's most targeted sectors include life science (100%).
The leading players of the Non-Alcoholic Steatohepatitis industry, their market share, product portfolio, company profiles are covered in this report. The leading market players are analyzed based on production volume, gross margin, market value, and price structure. The competitive market scenario among Non-Alcoholic Steatohepatitis players will help the industry aspirants in planning their strategies. The statistics offered in this report will be a precise and useful guide to shape business growth.
Global Non-Alcoholic Steatohepatitis Market Segmentation:
Market Segmentation: By Application
Market Segmentation: By Type
Regional and Country-level Analysis:
The key regions covered in the Non-Alcoholic Steatohepatitis market report are North America,
Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers
key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy,
Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia,
Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia,
U.A.E, etc.
North America holds the largest share of the non-alcoholic steatohepatitis (NASH) market, and the US accounts for the largest share of the regional market, followed by Canada and Mexico, respectively. The non-alcoholic steatohepatitis (NASH) market in the US is expected to grow rapidly with the growing cases of NASH and favorable government regulations encouraging the development of diagnostics procedures for this condition. On the International NASH Day on June 12, 2020, the American Liver Foundation joined a global community to raise awareness about NASH with support from the Allergan Foundation.
Get Special pricing with up to 30% Discount on the first purchase of this report:
https://www.marketintelligencedata.com/report/purchase/3419297?mode=su?mode=DivyA
Key questions answered in the report include:
What will the market size and the growth rate be in 2029?
What are the key factors driving the Global Non-Alcoholic Steatohepatitis Market?
What are the key market trends impacting the growth of the Global Non-Alcoholic Steatohepatitis Market?
What are the challenges to market growth?
Who are the key vendors in the Global Non-Alcoholic Steatohepatitis Market?
What are the market opportunities and threats faced by the vendors in the Global Non-Alcoholic Steatohepatitis Market?
Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA.
Explore Full Report With Detailed TOC Here:
https://www.marketintelligencedata.com/reports/3419297/non-alcoholic-steatohepatitis-nash-drugs-in-development-by-stages-target-moa-roa-molecule-type-and-key-players-2021-update?mode=DivyA
Crucial Elements from the Table of Contents of Global Non-Alcoholic Steatohepatitis Market:
- Non-Alcoholic Steatohepatitis Market Overview
- Global Non-Alcoholic Steatohepatitis Market Competition, Profiles/Analysis, Strategies
- Global Non-Alcoholic Steatohepatitis Capacity, Production, Revenue (Value) by Region (2016-2021)
- Global Non-Alcoholic Steatohepatitis Supply (Production), Consumption, Export, Import by Region (2016-2021)
- Global Non-Alcoholic Steatohepatitis Market Regional Highlights
- Industrial Chain, Sourcing Strategy, and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Market Effect Factors Analysis
- Market Decisions for the present scenario
- Global Non-Alcoholic Steatohepatitis Market Forecast (2021-2029)
- Case Studies
- Research Findings and Conclusion
Finally, the Non-Alcoholic Steatohepatitis Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. The Non-Alcoholic Steatohepatitis industry report additionally presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
*If you need anything more than these then let us know and we will prepare the report according to your requirement.
Customization services available with the report:
-20% Free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization upto 40 hours.
-Post-sales support for 1 year from the date of delivery.
About Us:
Research Studies is a reliable source for market research reports that can give your company the edge it needs. Market intelligence data goal at Research Reports is to provide a platform for many top-notch market research businesses around the world to publish their research reports, as well as to assist decision-makers in selecting the most appropriate market research solutions all under one roof.
Contact Us:
Irfan Tamboli (Head of Sales) - Market Intelligence Data
Phone: + 1704 266 3234
sales@marketintelligencedata.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis Market Size 2021: leading players, Regional Production Volume, Opportunities, Segments and Forecast Analysis 2028 - 180 Life Corp, 180 Life Sciences Corp, 89bio Inc, AbbVie Inc here
News-ID: 2640424 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for Steatohepatitis
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis Treatment Market Size, Share
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.67 billion In 2028…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
Nonalcoholic Steatohepatitis Treatment Market Analysis
As per the research conducted by GME, the Global Nonalcoholic Steatohepatitis Treatment Market will grow with a CAGR value of 39.1% by 2026. Over the forecast era, the production of NASH biomarkers is expected to be aided by increasing demand for non-invasive diagnostic tools and increased patient awareness. The low use of invasive procedures for disease diagnosis is due to the high cost of liver biopsy, its invasiveness, and patients'…
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot
Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver.
Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely…
